Legend Biotech Corporation American Depositary Shares (LEGN) Stock
NASDAQ · LEGN
17.61
Fundamentals
Market cap
$3.42B
Price / Earnings ratio
-37.2x
Price / Sales ratio
2.7x
Price / Book ratio
2.8x
Return on assets
-0.1%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Legend Biotech Corporation American Depositary Shares
No description available.
SectorHealthcare
IndustryBiotechnology
Employees3,200
IPO DateJun 5, 2020
HeadquartersSomerset, NJ
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Carlos Santos Garcia | Chief Financial Officer | 1972 |
| Ms. Ananda Elizabeth Martin Esq., J.D. | Global Compliance Officer | 1974 |
| Mr. Robert Staloff | General Counsel | — |
| Dr. Ying Huang Ph.D. | Advisor | 1973 |
| Dr. Yuhong Qiu Ph.D. | Interim Head of Research & Development and Senior VP of Regulatory Affairs | — |
| Mr. Birk Vanderweeen | Senior Vice President of Global Manufacturing & Supply | — |
Fundamentals
Valuation
Market cap$3.42B
Price-to-sales ratio2.68
Price-to-book value2.77
Price-earnings ratio-37.20
Return on Equity-25.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.50
Income Statement
Average volume2,071,154
EBITDA$-175.56M
1 year high (52w)$37.50
1 year low (52w)$16.24
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



